Search results
Results from the WOW.Com Content Network
The Papanicolaou test (abbreviated as Pap test, also known as Pap smear (AE), [1] cervical smear (BE), cervical screening (BE), [2] or smear test (BE)) is a method of cervical screening used to detect potentially precancerous and cancerous processes in the cervix (opening of the uterus or womb) or, more rarely, anus (in both men and women). [3]
The Bethesda system (TBS), officially called The Bethesda System for Reporting Cervical Cytology, is a system for reporting cervical or vaginal cytologic diagnoses, [1] used for reporting Pap smear results. It was introduced in 1988 [2] and revised in 1991, [3] 2001, [1] [4] [5] and 2014. [6]
However, “a good rule of thumb is that women ages 21-29 should get a pap test every three years [and] women older than that continue getting paps every three years or choose to space out testing ...
The task force has introduced a recommendation that women over the age of 30 test for high-risk human papilloma viruses (HPV) every five years rather than relying on pap smears to detect cervical ...
For decades, a Pap smear has been the standard way to detect cervical cancer. The uncomfortable and, for some, painful procedure entails using a small brush or spatula to lightly scrape the cervix ...
A speculum exam is typically performed at the initial visit; the cervix typically appears bluish, which is a sign of increased blood flow. [24] A Pap test may be performed according to guidelines, and testing for Neisseria gonorrhea and Chlamydia trachomatis may be performed as indicated. [24]
Georgios Nikolaou Papanikolaou (or George Papanicolaou / ˌ p æ p ə ˈ n ɪ k ə l aʊ /; Greek: Γεώργιος Ν. Παπανικολάου [papanikoˈlau]; 13 May 1883 – 19 February 1962) was a Greek physician, zoologist and microscopist who was a pioneer in cytopathology and early cancer detection, and inventor of the pap smear for detection of cervical cancer.
Cervical cancer screening is a medical screening test designed to identify risk of cervical cancer. Cervical screening may involve looking for viral DNA, and/or to identify abnormal, potentially precancerous cells within the cervix as well as cells that have progressed to early stages of cervical cancer .